Immunological Regulation of Fibrosis During Heart Failure: It Takes Two to Tango
Immuno-fibrotic networks and their protein mediators, such as cytokines and chemokines, have increasingly been appreciated for their critical role in cardiac healing and fibrosis during cardiomyopathy. Immune activation, trafficking, and extravasation are tightly regulated to ensure a targeted and e...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Biomolecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-273X/15/1/58 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832588918310043648 |
|---|---|
| author | Vinay Kumar Shyam S. Bansal |
| author_facet | Vinay Kumar Shyam S. Bansal |
| author_sort | Vinay Kumar |
| collection | DOAJ |
| description | Immuno-fibrotic networks and their protein mediators, such as cytokines and chemokines, have increasingly been appreciated for their critical role in cardiac healing and fibrosis during cardiomyopathy. Immune activation, trafficking, and extravasation are tightly regulated to ensure a targeted and effective response against non-self antigens/pathogens while preserving tolerance towards self-antigens and coordinate fibrotic responses for efficient scar formation, a distinction that is severely compromised during chronic diseases. It is clear that immune cells are not only the critical regulators of post-infarct healing and scarring but are also the key players in regulating fibroblast activation during left-ventricular (LV) remodeling. Incomplete resolution coupled with sustained low-grade inflammation during dilated cardiomyopathy precipitates a “frustrated” immune cell response resulting in unconstrained pro-fibrotic and pro-hypertrophic signaling to induce maladaptive structural and functional changes in the myocardium. The aims of this review are to (i) briefly summarize the role of key immune cells that regulate wound healing during MI and fibrosis during LV remodeling; (ii) underscore phenotypic diversities in immune cells and their subsets to underscore their role in regulating fibrotic responses, and, last but not the least, (iii) highlight gaps in our understanding that restrict the translation of immuno-modulatory therapies from the preclinical models to heart failure patients. |
| format | Article |
| id | doaj-art-97ed5bfb3e9a4d7f8b40be0c68752a09 |
| institution | Kabale University |
| issn | 2218-273X |
| language | English |
| publishDate | 2025-01-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Biomolecules |
| spelling | doaj-art-97ed5bfb3e9a4d7f8b40be0c68752a092025-01-24T13:25:01ZengMDPI AGBiomolecules2218-273X2025-01-011515810.3390/biom15010058Immunological Regulation of Fibrosis During Heart Failure: It Takes Two to TangoVinay Kumar0Shyam S. Bansal1Heart and Vascular Institute, Pennsylvania State University Hershey Medical Center, Hershey, PA 17033, USAHeart and Vascular Institute, Pennsylvania State University Hershey Medical Center, Hershey, PA 17033, USAImmuno-fibrotic networks and their protein mediators, such as cytokines and chemokines, have increasingly been appreciated for their critical role in cardiac healing and fibrosis during cardiomyopathy. Immune activation, trafficking, and extravasation are tightly regulated to ensure a targeted and effective response against non-self antigens/pathogens while preserving tolerance towards self-antigens and coordinate fibrotic responses for efficient scar formation, a distinction that is severely compromised during chronic diseases. It is clear that immune cells are not only the critical regulators of post-infarct healing and scarring but are also the key players in regulating fibroblast activation during left-ventricular (LV) remodeling. Incomplete resolution coupled with sustained low-grade inflammation during dilated cardiomyopathy precipitates a “frustrated” immune cell response resulting in unconstrained pro-fibrotic and pro-hypertrophic signaling to induce maladaptive structural and functional changes in the myocardium. The aims of this review are to (i) briefly summarize the role of key immune cells that regulate wound healing during MI and fibrosis during LV remodeling; (ii) underscore phenotypic diversities in immune cells and their subsets to underscore their role in regulating fibrotic responses, and, last but not the least, (iii) highlight gaps in our understanding that restrict the translation of immuno-modulatory therapies from the preclinical models to heart failure patients.https://www.mdpi.com/2218-273X/15/1/58inflammationmonocytes and macrophagesT cellsmyocardial infarctionischemic heart failure |
| spellingShingle | Vinay Kumar Shyam S. Bansal Immunological Regulation of Fibrosis During Heart Failure: It Takes Two to Tango Biomolecules inflammation monocytes and macrophages T cells myocardial infarction ischemic heart failure |
| title | Immunological Regulation of Fibrosis During Heart Failure: It Takes Two to Tango |
| title_full | Immunological Regulation of Fibrosis During Heart Failure: It Takes Two to Tango |
| title_fullStr | Immunological Regulation of Fibrosis During Heart Failure: It Takes Two to Tango |
| title_full_unstemmed | Immunological Regulation of Fibrosis During Heart Failure: It Takes Two to Tango |
| title_short | Immunological Regulation of Fibrosis During Heart Failure: It Takes Two to Tango |
| title_sort | immunological regulation of fibrosis during heart failure it takes two to tango |
| topic | inflammation monocytes and macrophages T cells myocardial infarction ischemic heart failure |
| url | https://www.mdpi.com/2218-273X/15/1/58 |
| work_keys_str_mv | AT vinaykumar immunologicalregulationoffibrosisduringheartfailureittakestwototango AT shyamsbansal immunologicalregulationoffibrosisduringheartfailureittakestwototango |